What Researchers Did
Researchers analyzed data from a NASA database of 516 individuals to determine if Doppler-detectable microbubbles could help diagnose decompression sickness and guide treatment decisions.
What They Found
The Doppler test was useful for both screening and confirming decompression sickness, using different criteria for a positive test. Calculations showed that early recompression was optimal when the post-test probability of disease was greater than 0.25 for non-specific pain at altitude, and early recompression with 100% oxygen for 2 hours was optimal when this probability exceeded 0.33. Hyperbaric therapy was deemed optimal when the post-test probability was greater than 0.04 for uncertain symptoms after flight.
What This Means for Canadian Patients
For Canadian patients experiencing decompression sickness, particularly those with non-specific or uncertain symptoms, the Doppler test could provide valuable information to guide treatment. This could help physicians decide when to initiate recompression therapy, including hyperbaric oxygen treatment, ensuring timely and appropriate care. Such guidance is crucial for a condition like decompression sickness where prompt intervention can significantly improve outcomes.
Canadian Relevance
This study covers decompression sickness, which is a Health Canada-recognized indication for hyperbaric oxygen therapy. No direct Canadian connection was identified regarding authors or study location.
Study Limitations
The study analyzed existing data from a NASA database, which may not fully represent all populations at risk for decompression sickness.